In this study, we selected 58
styrene-exposed workers, measured personal styrene exposure, evaluated genotypes
relevant drug-metabolizing enzymes (CYP2E1, EPHX1, GSTM1 and GSTT1) which may
explain the variability in the urinary metabolite excretion. The results showed
that, in different levels of styrene exposure groups, there is a significant association
between urinary metabolites and some genotypes of styrene-metabolizing enzymes,
including CYP2E1 (5-flanking region, RsaI/PstI), GSTM1(gene deletions) and EPHX1(predicted
Cite this paper
Qu, W. and Zhang, F. (2015) Influence of Genetic Polymorphism of Styrene-Metablizing Enzymes on Occupational Exposure Monitoring to Styrene. Journal of Biosciences and Medicines
, 35-38. doi: 10.4236/jbm.2015.33005
 Sarmaovvá, J., Tynková, L., Süsová, S., Cut, I. and Soucek, P. (2000) Genetic Polymorphisms of Biotransformation Enzymes: Allele Frequencies in the Population of Czech Republic. Pharmacogenetics, 10, 781-788.
 VeMina, A, Galati, R., Falasca, G., et al. (2001) Metabolic Polymorphisms and Urinary Biomarkers in Subjects with Low Benzene Exposure. Journal of Toxicology and Environmental Health, 64, 607-618.
 Kim, H., Wang, R.S., Elovaara, E., et al. (1997) Cytochrome P450 Isoenzymes Responsible for the Metabolism of Toluene and Styrene in Human Liver Microsomes. Xenobiotica, 27, 657-665.